Neue monoklonale Antikörper und ihr Einsatz in der Dermatologie

Advances in immunological research and progress in molecular methods have led to the development of new therapeutic strategies compassing monoclonal antibodies and fusion proteins in the last years. These immunomodulators which are directed against key components of immunological processes have been designed in an attempt to produce safer and more selective immunosuppressive agents. This review summarizes much of the available literature describing the use of monoclonal antibodies and fusion proteins in the treatment of dermatological diseases.